NRC Health (NRC) stock
NRCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/3078% above fair value
$26.16+0.27 (+1.06%)
Close on Nov 18, 2026Market cap $578.65MP/E –Yield 1.99%
NRC Health r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for NRC Health
NRC Health has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?